Leigh Colby, Director, President & CEO
Leigh Colby, President & CEOFrom 1995 through 2015 Dr. Colby was the founder, CEO and sole shareholder of Oregon Dental Care, a successful group dental practice in Oregon that delivers high quality patient care in a zero defect operating environment. Oregon Dental Care was acquired by InterDent in late 2015 where he served as the Managing Clinical Director. Prior to starting Oregon Dental Care in 1995 Dr. Colby was involved with three high-tech startups that all remain in successful operation today. In 1980 he was the principal founder of Laserdyne Corporation and wrote the ground-breaking specifications for the successful high-resolution Beam Director general-purpose CNC laser machining system. The Beam Director system remains the #1 selling general-purpose laser machining system worldwide. In 1984 he assisted the PhD EE founder of Cyberoptics Corporation in defining their initial product specifications and market applications to establish initial distribution channels for their unique high resolution, non-contact laser gauging and automated inspection products. Dr. Colby worked with CyberOptics to develop and implement a marketing plan which drove initial product sales, and propelled them to a market leader, where they remain today. In 1986 Dr. Colby teamed up with three PhD-level biochemists as their Vice President of Marketing to define and establish their first commercial operations for Surmodics, Inc. His 10-year effort at Surmodics ultimately resulted in revenues approaching $100M annually for the use of PhotoLink high-reliability biocompatibility enhancement technology on a variety of widely recognized implant and disposable medical devices. Surmodics remains a publicly traded operation. Dr. Colby has earned his M.B.A. degree from Northwest Christian University, D.D.S. and B.S. degrees from the University of Minnesota, B.S. degree from St. John’s University and is a certified Lean Six Sigma Master Black Belt.
Dave Watson. Director & Chief of Operations
Dave Watson, Chief of OperationsDave Watson brings 25 years of leadership experience to the management team at TriAgenics, Inc. Mr. Watson worked for 15 years with IBM in Engineering, Manufacturing, and Product Development where he held key technical and senior management positions, including critical strategist at IBM Technology Products Division headquarters. He filled the positions of Director of Technology at Planar Systems, Inc., Director of Engineering at Fujitsu Ltd., Director of Manufacturing at Biotronik, Inc and VP of Engineering at Unilife Medical Solutions, Inc. Mr. Watson has patents in the fields of automated equipment and technology products. Mr. Watson is the Chief of Operations at TriAgenics, Inc. and is responsible for quality assurance, regulatory affairs, product development and manufacturing. He holds an MSME from the University of Texas and a BSME from California Polytechnic State University in California.
Walter "Mick" Diers, Director & Chief Financial Officer
Mick Diers, Chief Financial OfficerMr. Diers, with a BS in Business and an MBA, has risen through the ranks from accountant to controller to senior financial officer, while serving with multiple companies. As a founder of Laserdyne Corporation he wrote the financial portion of the business plan that ultimately led to the funding of the company in 1981. Once funded, he established the accounting and reporting system, wrote and implemented all administrative and human resource policies, and managed the hiring process of the first 36 employees. In 1987, while working as an independent consultant, Mr. Diers was retained by SurModics, Inc. to assist in the development of a strategic and financial plan. After assessing the developmental and intellectual property status, as well as the market potential of the company’s technologies, Mr. Diers recommended that SurModics concentrate on its surface modification technology. Mr. Diers was hired as a corporate officer of SurModics shortly thereafter and immediately tasked with writing a funding prospectus and managing the fund-raising process. Mr. Diers managed four rounds of fund-raising ultimately raising $13,000,000. SurModics’ primary revenues came from a licensing strategy. Mr. Diers negotiated more than 100 licenses while also serving as the senior financial officer of SurModics. Prior to going public in 1998, Mr. Diers’ position was split into two positions with Mr. Diers remaining in charge of all licensing activities and with the added responsibility of managing the company’s patent and intellectual property position. Throughout his career Mr. Diers has been able to perform and manage the day-to-day detail while clearly defining the path to attain the strategic goals and vision of the company.
John Chopack, Jr. , Director
John Chopak, Jr, DirectorMr. Chopack is a Principal and founding partner of Inspiros. Mr. Chopack manages the day to day operations of Inspiros and is responsible for investment origination, portfolio company management and investor relations. Mr. Chopack has 14 years of experience in venture capital investing in medtech companies. As a General Partner at HealthpointCapital, a $800 million AUM medtech focused private equity firm, Mr. Chopack played an integral role in the firm’s most profitable investments – Nexa Orthopedics, BioHorizons and Blue Belt Technologies. These investments brought significant advances to the healthcare field and provided top quartile returns to investors.
Prior to his career in venture capital, Mr. Chopack was an orthopedic sales representative for Wright Medical and Encore Orthopedics. Following his experience as an orthopedic sales representative, Mr. Chopack worked on Wall Street with Investec and Techvest as a medtech analyst.
Mr. Chopack has been recognized as a “40 under 40 Medtech Innovator” by Medical Device and Diagnostic Industry Magazine.
Mr. Chopack received a BA from Lafayette College and an MBA from Fordham University Gabelli School of Business.
George Shahin, Director
George Shahin, M.D. DirectorDr. Shahin is a Principal and founding partner of Inspiros. As the Chief Medical Officer, Dr. Shahin leads the review process and analysis of medical devices and healthcare technologies. Dr. Shahin brings Inspiros his experience as a practicing physician focused on evidence based medicine, patient outcomes and value based care. As a Gastroenterologist at the Family Health Centers at NYU Langone, Dr. Shahin has served as Chair of the Medical and Surgical division of Value Analysis – a health center initiative aimed at improving patient outcomes while reducing cost through a multidisciplinary, physician-led, evidence-based purchasing program. Dr. Shahin has also been instrumental in the health center’s effort to double the colon cancer screening rates of patients through the implementation of evidence based screening programs. He has studied the impact of these programs and published the results in peer reviewed journals.
Dr. Shahin is Board Certified in Internal Medicine and Gastroenterology by the American Board of Internal Medicine. He is a member of the American College of Gastroenterology, American Medical Association, and American Association for Physician Leadership.
Dr. Shahin received a BA from Lafayette College, an MD degree from Ross University School of Medicine, and an MBA from The University of Massachusetts Amherst Isenberg School of Management.
David Thrower, Director
David ThrowerDavid Thrower joined as a Director of Triagenics in October of 2020. David has held executive leadership roles in a variety of companies in medical device markets where he has over 25 years of experience. The majority of his career has been spent at the intersection of the consumer and medical device spaces. His roles have included VP of Global Marketing at Align Technology, the makers of Invisalign (invisible orthodontic aligners), from its early revenues through ~$200m in sales, CEO of InSound Medical, a disruptive play in the hearing device space (purchased by Sonova in 2011), and CEO of Asante Solutions where David successfully shepherded an insulin pump through FDA approval and early commercial launch. David’s early career and education include six years at the strategy firm of Bain and Company, an MBA from Harvard Business School and a BS in Mathematical and Computational Sciences from Stanford University.

Pro Forma Website

This is a pro forma website based solely upon animal study data. TriAgenics’ Zero3™ 3TBA procedure is not approved for human use.